FAM
ITCI
Fred Alger Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-16,564
| Closed | -$1.13M | – | 485 |
|
2024
Q2 | $1.13M | Buy |
16,564
+4,030
| +32% | +$276K | 0.01% | 352 |
|
2024
Q1 | $867K | Buy |
+12,534
| New | +$867K | ﹤0.01% | 376 |
|
2022
Q4 | – | Sell |
-38,536
| Closed | -$1.79M | – | 576 |
|
2022
Q3 | $1.79M | Sell |
38,536
-46,184
| -55% | -$2.15M | 0.01% | 349 |
|
2022
Q2 | $4.84M | Sell |
84,720
-21,008
| -20% | -$1.2M | 0.02% | 267 |
|
2022
Q1 | $6.47M | Buy |
+105,728
| New | +$6.47M | 0.02% | 250 |
|
2017
Q4 | – | Sell |
-20,000
| Closed | -$316K | – | 598 |
|
2017
Q3 | $316K | Buy |
20,000
+7,000
| +54% | +$111K | ﹤0.01% | 371 |
|
2017
Q2 | $161K | Buy |
+13,000
| New | +$161K | ﹤0.01% | 393 |
|
2016
Q3 | – | Sell |
-5,200
| Closed | -$202K | – | 541 |
|
2016
Q2 | $202K | Buy |
+5,200
| New | +$202K | ﹤0.01% | 415 |
|
2015
Q4 | – | Sell |
-6,700
| Closed | -$268K | – | 596 |
|
2015
Q3 | $268K | Sell |
6,700
-25,750
| -79% | -$1.03M | ﹤0.01% | 460 |
|
2015
Q2 | $1.04M | Sell |
32,450
-132,347
| -80% | -$4.23M | ﹤0.01% | 425 |
|
2015
Q1 | $3.94M | Buy |
+164,797
| New | +$3.94M | 0.02% | 367 |
|